KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Non-Current Assets (2017 - 2025)

Historic Non-Current Assets for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to $1.8 billion.

  • Amneal Pharmaceuticals' Non-Current Assets fell 956.46% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 billion, marking a year-over-year decrease of 952.03%. This contributed to the annual value of $1.9 billion for FY2024, which is 864.4% down from last year.
  • As of Q3 2025, Amneal Pharmaceuticals' Non-Current Assets stood at $1.8 billion, which was down 956.46% from $1.8 billion recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Non-Current Assets registered a high of $2.5 billion during Q1 2022, and its lowest value of $1.8 billion during Q3 2025.
  • Its 5-year average for Non-Current Assets is $2.2 billion, with a median of $2.3 billion in 2023.
  • Its Non-Current Assets has fluctuated over the past 5 years, first soared by 411.93% in 2022, then tumbled by 1269.92% in 2024.
  • Amneal Pharmaceuticals' Non-Current Assets (Quarter) stood at $2.4 billion in 2021, then fell by 1.32% to $2.4 billion in 2022, then dropped by 12.26% to $2.1 billion in 2023, then decreased by 8.64% to $1.9 billion in 2024, then fell by 7.96% to $1.8 billion in 2025.
  • Its Non-Current Assets was $1.8 billion in Q3 2025, compared to $1.8 billion in Q2 2025 and $1.9 billion in Q1 2025.